Fernando Martín Guerra-Infante

Prof. Dr. Fernando Martín Guerra-Infante

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2001 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
DHDavid Hubacher
David Hubacher
RLRoger Lara-Ricalde
Roger Lara-Ricalde
DTDouglas J. Taylor
Douglas J. Taylor
FGFernando Martín Guerra-Infante
Fernando Martín Guerra-Infante
RGRaymundo Guzmán-Rodríguez
Raymundo Guzmán-Rodríguez
Previous studies of intrauterine devices (IUDs), many of which are no longer in use, suggested that they might cause tubal infertility. The concern that IUDs that contain copper — currently the most commonly used type — may increase the risk of infertility in nulligravid women has limited the use of this highly effective method of birth control.

20 March 2006 in Human Reproduction
Verified
Journal Article
Open access
PDF file
FDFrancisco Javier Díaz-García
Francisco Javier Díaz-García
AHAlma Patricia Herrera-Mendoza
Alma Patricia Herrera-Mendoza
SGSilvia Giono-Cerezo
Silvia Giono-Cerezo
FGFernando Martín Guerra-Infante
Fernando Martín Guerra-Infante
BACKGROUND: The study of sperm–mycoplasma interaction has been focused on the effects of infection on sperm quality, but few studies have reported the direct interaction of this bacterium with spermatozoa. METHODS: Selected populations of viable, motile and infection-free human spermatozoa from three healthy men were incubated with 15–480 multiplicity of infection (MOI) units of DiIC18-labelled Mycoplasma hominis. Cells were analyzed by means of confocal microscopy and by the eosin-Y dye exclusion test between 10 min and 24 h post-infection. RESULTS: As early as 10 min post-infection, clusters of M. hominis were seen attached to the sperm head, midpiece or tail. Mycoplasma showed an approximately 2.5–4.5-fold higher interaction with sperm head or tail than with midpiece. Sequential sectioning of infected spermatozoa revealed the intracellular location of M. hominis within cytosolic spaces of head and midpiece regions. A minor proportion of infected spermatozoa showed bent or coiled tails, and/or midpiece thickening. Sperm viability was not altered by M. hominis infection. CONCLUSIONS: These results provide specific and conclusive evidence of M. hominis attachment and invasiveness towards human sperm cells, which seems not to affect their viability, suggesting that a short-term M. hominis interaction with spermatozoa results in non-apparent or subtle damage, but might have implications for long-term male or couple’s fertility.

1 February 2011 in Enfermedades Infecciosas y Microbiología Clínica
Verified
Journal Article
Closed access
MHMaria de Jesús De Haro-Cruz
Maria de Jesús De Haro-Cruz
IDIrma Deleón-Rodriguez
Irma Deleón-Rodriguez
MEMarcos R. Escobedo-Guerra
Marcos R. Escobedo-Guerra
MLMarcela López-Hurtado
Marcela López-Hurtado
GAGabriel Arteaga-Troncoso
Gabriel Arteaga-Troncoso
FGFernando Martín Guerra-Infante
Fernando Martín Guerra-Infante

12 January 2011 in Human Reproduction Update
Verified
Journal Article
Open access
PDF file
KBK.A. Broeze
K.A. Broeze
BOB.C. Opmeer
B.C. Opmeer
SCS.F.P.J. Coppus
S.F.P.J. Coppus
NGN. Van Geloven
N. Van Geloven
MAM.F.C. Alves
M.F.C. Alves
BMB.W. Mol
B.W. Mol
BACKGROUND The Chlamydia IgG antibody test (CAT) shows considerable variations in reported estimates of test accuracy, partly because of the use of different assays and cut-off values. The aim of this study was to reassess the accuracy of CAT in diagnosing tubal pathology by individual patient data (IPD) meta-analysis for three different CAT assays. METHODS We approached authors of primary studies that used micro-immunofluorescence tests (MIF), immunofluorescence tests (IF) or enzyme-linked immunosorbent assay tests (ELISA). Using the obtained IPD, we performed pooled receiver operator characteristics analysis and logistic regression analysis with a random effects model to compare the three assays. Tubal pathology was defined as either any tubal obstruction or bilateral tubal obstruction. RESULTS We acquired data of 14 primary studies containing data of 6191 women, of which data of 3453 women were available for analysis. The areas under the curve for ELISA, IF and MIF were 0.64, 0.65 and 0.75, respectively (P-value < 0.001) for any tubal pathology and 0.66, 0.66 and 0.77, respectively (P-value = 0.01) for bilateral tubal pathology. CONCLUSIONS In Chlamydia antibody testing, MIF is superior in the assessment of tubal pathology. In the initial screen for tubal pathology MIF should therefore be the test of first choice.

22 November 2005 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
PDF file
GAGabriel Arteaga‐Troncoso
Gabriel Arteaga‐Troncoso
AVAlejandro Villegas‐Alvarado
Alejandro Villegas‐Alvarado
ABAurora Belmont‐Gomez
Aurora Belmont‐Gomez
FMFrancisco J. Martinez‐Herrera
Francisco J. Martinez‐Herrera
RVRoberto Villagrana‐Zesati
Roberto Villagrana‐Zesati
FGFernando Martín Guerra-Infante
Fernando Martín Guerra-Infante
Objective To determine the therapeutic efficacy and safety of a nitric oxide (NO) isosorbide dinitrate donor to induce cervical ripening of women with missed abortions before surgical evacuation of the uterus. Design A prospective, randomised, double‐blind controlled trial. Setting Tertiary referral maternity teaching hospital. Population Sixty women with missed abortions and no cervical dilation. Methods Women requesting surgical evacuation of the uterus were randomly selected to receive endocervical 80 mg/1.5 mL isosorbide dinitrate gel solution (n= 30) or 400 μg/1.5 mL misoprostol gel solution (n= 30) every 3 hours to a maximum of four doses or until reaching cervical ripening. Vital signs and symptoms were recorded at baseline and then every 3 hours until finishing therapy. Adverse events, such as headache, abdominal pain, pelvic pain, backache, nausea and vomiting, were evaluated. Main outcome measures Probability of reaching cervical ripening >8 mm Hegar dilator; evaluated at 3, 6, 9 and 12 hours after application of isosorbide dinitrate or misoprostol. Results The probabilities of induction of cervical ripening by isosorbide dinitrate and misoprostol after four repeated doses at 3‐hour intervals were significantly different (P < 0.001). Efficacy of therapy after 12 hours was 97% for the isosorbide dinitrate group and 70% for the misoprostol group. Systolic and diastolic blood pressures were lower after administration of isosorbide dinitrate than prostaglandin analogues. The difference in the mean systolic and diastolic blood pressure between treatment groups was greatest at 3 hours, with a difference of 7.7 mmHg (P < 0.001) and 5.9 mmHg (P < 0.003), respectively. The most frequent side effect associated with isosorbide dinitrate administration was headache, which occurred in 18 out of 30 patients, compared with only 5 out of 30 women in the misoprostol group [relative risk (RR) 2.41, 95% confidence interval (CI) 1.45–4.03, P < 0.001). Women treated with misoprostol reported mainly pelvic pain (RR 3.24, 95% CI 1.99–5.27, P < 0.001). Conclusions Intracervical administration of 80 mg isosorbide dinitrate in women with missed abortions appears to be effective for cervical ripening prior to surgical evacuation of the uterus. Differences in the incidence of non‐serious adverse events are not likely to be clinically significant.

11 April 2019 in International Microbiology
Verified
Journal Article
Closed access
PDF file
MHMaría J. de Haro-Cruz
María J. de Haro-Cruz
SGSandra I. Guadarrama-Macedo
Sandra I. Guadarrama-Macedo
MLMarcela López-Hurtado
Marcela López-Hurtado
MEMarcos R. Escobedo-Guerra
Marcos R. Escobedo-Guerra
FGFernando Martín Guerra-Infante
Fernando Martín Guerra-Infante